Influenzinum 200C
- Product NDC
- 44911-0631
- Requested package NDC
- 44911-0631-1
- 11-digit product format
- 449110631
- Labeler code
- 44911
- Product ID
- 44911-0631_685ce6cf-ed03-4913-85bb-f6de4585a001
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Influenzinum (2020-2021)
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Energique, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2020-12-30
- Marketing end
- 2026-01-05
- Substance
- INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)
- Active strength
- 200 [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 44911-0631 | INFLUENZINUM 200C (INFLUENZINUM (2020-2021)) LIQUID [ENERGIQUE, INC.] | 3 | Legacy NDC | 20220216_8a65cff7-04b5-4179-951c-b4ecb42a2306.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 44911-0631-1 | 44911063101 | 30 mL in 1 BOTTLE, DROPPER (44911-0631-1) | 30 ml | 2020-12-30 | 2026-01-05 | No | No | Current |